Three-year longitudinal assessment of denosumab's efficacy and safety in postmenopausal osteoporosis: a 36-month real-world cohort study. [PDF]
Xia RL, Li C, Wang L, Chao AJ, Wei W.
europepmc +1 more source
Bone-Targeted Therapies and Spinal Morphometry in Postmenopausal Osteoporosis: A Real-World Longitudinal Retrospective Study. [PDF]
Wu ZW +10 more
europepmc +1 more source
Macrophage polarization regulates bone homeostasis: a potential etiology and therapy for postmenopausal osteoporosis. [PDF]
Danzeng Q +6 more
europepmc +1 more source
A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review. [PDF]
Mann RS +6 more
europepmc +1 more source
MiR-642a-3p increases the risk of postmenopausal osteoporosis and fractures by targeting INO80. [PDF]
Zhang J, Xiao H.
europepmc +1 more source
Integrated single-cell and experimental analyses implicate GPRC5B in macrophage senescence-related alterations in postmenopausal osteoporosis. [PDF]
Zhao S, Yang Y, Meng J, Yang Z, Jiang X.
europepmc +1 more source
Postmenopausal osteoporosis and vascular calcification: The estrogen regulation network and calcification paradox. [PDF]
Lin Y, Jiang P, Lv Y, Tian W.
europepmc +1 more source
Associations of pregnancies and livebirths with postmenopausal osteoporosis odds and modifying effects of physical activity. [PDF]
Wang X +7 more
europepmc +1 more source
17β-Estradiol Maintains Mitochondrial Homeostasis in Osteoblasts by Inhibiting MMP-8 and Activating the Ras Signaling Pathway in Postmenopausal Osteoporosis. [PDF]
Min H +6 more
europepmc +1 more source
Identification of key predictors of postmenopausal osteoporosis from routine clinical indicators using explainable machine learning. [PDF]
Guo Y +7 more
europepmc +1 more source

